Skip to main content
BannerInterno

Scientific Program

  • THURSDAY 22ND APRIL PRE-CONGRESS COURSE: ANDROLOGY
    08:50 - 10:40
    ROOM 5

    		 SESSION 1: SOS, SPERM NOT FOUND: THERAPIES REGENERATING SPERM PRODUCTION ON AZOOSPERMIC MALES WITH FAILED TESE
    Chair: Jim Hotaling
     8:50-9:00 Introduction
    N. Garrido (Spain)
     9:00-9:30 The use of PRP on restoring spermatogenesis, what the evidence says
    B. Tiras (Turkey)
     9:30-10:00 Use of isothiotreonine
    S. Lujan (Spain)
     10:00-10:30 Use of hormonal therapies. How to prime spermatogenesis based on endocrinology
    A. Ferlin (Spain)
     10:30-10:40 Questions
     10:45-11:15 COFFEE BREAK
    11:15 - 12:55
    ROOM 5    		 SESSION 2: CELLULAR BIOLOGY APPROACH
    Chair: Nicolás Garrido
    11:15-11:45 Spermatogonial stem cells
    TBC
     11:45-12:15 Cellular reprogramming and iPSCs
    K. Hayashi (Japan)
    12:15-12:45 Testicular organoids and Testis on a chip
    E. Goossens (Belgium)
    12:45-12:55 Questions
  • THURSDAY 22ND APRIL PRE-CONGRESS COURSE: TIPS & TRICKS OF DAILY PRACTICE IN IVF
    9:00-11:15
    ROOM 4    		 SESSION 1
    9:00-9:15 Welcome
    9:15-9:45 When is the natural cycle the preferred approach, and how should we manage it in daily practice?
    S. Santos-Ribeiro (Portugal)
    9:45–10:15 What is the best strategy when HRT is the treatment of choice?
    J. Serna (Spain)
    10:15–10:45 Progesterone levels in real-world clinical practice: what should we do?
    E.Labarta (Spain)
     10:45-11:15 COFFEE BREAK
    11:15-12:55
    ROOM 4
    		 SESSION 2
    11:15-11:45 Do fresh oocytes and embryos really matter in oocyte donation?
    M. J. de los Santos (Spain)
    11:45-12:15 Management of adenomyosis in patients wishing to conceive
    M. Cozzolino (Italy)
    12:15-12:45 Chronic endometritis: infectious or inflammatory disease? Current management strategies
    S. Quenby (UK)
    12:45-12:55 Closing remarks
  • THURSDAY 22ND APRIL PRE-CONGRESS COURSE: GENETICS
    08:30-08:40 Welcome and introduction
    M. Popovic (Spain)
    8:40-10:45
    ROOM 3
    		 SESSION 1: CLINICAL SCIENCE
    8:40-9:00 Why the genetics laboratory matters: understanding variability in PGT-A
    M. Popovic (Spain)
    9:00-9:20 The last word on mosaicism
    P. Gill (USA)
    9:20-9:40 Manifesting carriers: more than a reproductive risk
    J. Pla (Spain) 
    9:40-10:00 Rethinking PGT-M
    A.Iturriaga (USA)
    10:00-10:20 Your patients are asking for more: emerging technologies in embryo testing and intervention
    D. Wells, (UK)
    10:20-10:45  Panel discussion: Beyond the evidence, who decides?
    Panelists: TBD
    10:45-11:15 COFFEE BREAK
    11:15-12:35
    ROOM 3
    		 SESSION 2: CLINICAL SCIENCE
    11:15-11:35 Building the PGT pathway: the IVF laboratory perspective
    M. Florensa (Spain)
    11:35-11:55 When DNA contamination changes the PGT-A result
    G. Clark (UK)
    11:55-12:15 Building the PGT pathway: the clinical perspective
    L. Chapman (UK)
    12:15-12:35 Panel discussion: Beyond the biopsy: elevating PGT through collaboration
    Panelists: TBD
THURSDAY 22ND APRIL
14:00 - 16:10
AUDITORIUM ILLES BALEARS 
 HOW DOES AI HELP US IN THE CLINIC 
14:00 - 14:20 Ovarian estimulation for IVF and AI
E. Labarta (Spain)
14:20 - 14:40 Automated folliculometry: the way forward
E. Lara (Spain)
14:40 - 15:00 AI and lab automation in the IVF lab: a reality today
M. Meseguer (Spain)
15:00 - 15:20 Novel concepts in endometrial imaging and AI
J. García Velasco (Spain)
15:20 - 15:40 How AI can help our patients: improving patient journey
L. Rienzi (Italy)
15:40 - 16:10 Debate 1: One euploid embryo, one chance: to testo the endometrium or not
YES: N. Macklon (UK)
NO: P. Pirtea (France)
16:10 - 16:30 COFFEE BREAK
16:30 - 18:00
AUDITORIUM ILLES BALEARS 
 NEW CHALLENGES IN IVF
16:30 - 16:50 Current approaches to in vitro maturation: CAPA-IVM and rescue GV oocytes
M. J. Escriba (Spain)
16:50 - 17:10 What is new in oocyte vitrification: protocols and assessment of competence
A. Cobo (Spain)
17:10 - 17:30 The dismorphic uterus: how hysteroscopy help in 2027?
L. Pacheco (Spain)
17:30 - 18:00 Debate 2: Can pharmacogenomics truly personalize OS?
YES: C. Alviggi (Italy)
NO: E. Bosch (Spain)
18:00 - 19:00 INDUSTRY SPONSORED SYMPOSIUM
  • FRIDAY 23RD APRIL
    08:00 - 09:00 INDUSTRY SPONSORED SYMPOSIUM
    09:00 - 10:30
    AUDITORIUM ILLES BALEARS 
    		 OBESITY AND REPRODUCTIVE OUTCOMES IN ART: WEIGHTING THE ODDS
    09:00 - 09:20 The impact of obesity on reproductive function
    R. Anderson (UK)
    09:20 - 09:40 Clinical outcomes up to and beyond live birth
    J. Bellver (Spain)
    09:40 - 10:00 Fix it before you try it: lifestyle, medical treatments and surgery
    W. Vitek (USA)
    10:00 - 10:30 Debate 3: Fertility supplements in ART. To prescribe or to stop
    YES: J. Chamarro (USA)
    NO: G. Fagozzi (Italy)
    10:30 - 11:00 COFFEE BREAK  
    11:00 - 12:50
    AUDITORIUM ILLES BALEARS 
    		 NOVEL VENUES IN ADVANCED MATERNAL AGE
    11:00 - 11:20 Exploring oocytes from funamental mecanisms to new fundamental prespectives
    M. Schuh (Germany)
    11:20 - 11:40 Poor oocyte quality: beyond advanced maternal age
    H. Picton (UK)
    11:40 - 12:00 Ovarian stiffness and ovarian aging
    F. Amargant (Spain)
    12:00 - 12:20 New medical therapies for AMA: NMN and rapamycin
    S. Herraiz (Spain)
    12:20 - 12:50 Debate 4: AI embryo ranking is ready for routine clinical decision support
    YES: J. Swain (USA)
    NO: D. Sakkas (USA)
    12:50 - 13:50 LUNCH
    13:50 - 15:10
    AUDITORIUM ILLES BALEARS 
    		 DNA FRAGMENTATION: SPERM, OOCYTE AND EMBRYO
    13:50 - 14:10 Contributing factors affecting sperm DNA fragmentation
    A. Pacheco (Spain)
    14:10 - 14:30 The oocyte capacity in sperm DNA repairing
    E. Hoffman (Denmark)
    14:30 - 14:50 Embryo generated DNA damage during cleavage
    TBC
    14:50 - 15:10 When are DNA fragmentation tests useful and to manage abnormal results
    P. Humaidan (Denmark)
    15:10 - 15:40 COFFEE BREAK 
    15:40 - 16:40 INDUSTRY SPONSORED SYMPOSIUM
    16:40 – 17:10 Edwards prize
    17:10 – 19:00
    AUDITORIUM ILLES BALEARS 
    		 ADENOMYOSIS, THE NEW KID ON THE BLOCK
    17:10 – 17:30 Understanding progesterone resistance: from pathophysiology to clinical impact
    H. Taylor (USA)
    17:30 – 17:50 How much can ultrasound help us in adenomyosis?
    J. L. Alcázar (Spain)
    17:50 – 18:10 New alternatives for medical treatment of adenomyosis
    M. Cozzolino (Italy)
    18:10 – 18:30 Is surgery ever indicated in adenomyosis?
    G. Moawad (USA)
    18:30 – 19:00 Debate 5: Programmed FET should no longer be the default in ovulatory patients
    YES: F. von Versen (Germany)
    NO: N. Polyzos (Spain)
  • FRIDAY 23RD APRIL - EMBRYOLOGY
    08:30 - 10:30
    AUDITORIUM MALLORCA 
    		 SESSION 1 EMBRYOLOGY
    8:30 - 9:00 Unlocking oocyte activation: key role or overused strategy?
    T. Ebner (USA)
    9:00 - 9:30 Are cytokine-enriched media the missing link in FET success
    F. Bronet (Spain)
    9:30 - 10:00 Chromosomal instability and developmental competence in human embryos
    M. Popovic (Spain)
    10:00-10:30 Debate 1: Laboratory automation will be the standard of care in IVF labs
    YES: A. Chavez (Spain)
    NO: T. Freour (USA)
    10:30 - 11:00 COFFEE BREAK
    11:00 - 13:00
    AUDITORIUM MALLORCA 
    		 SESSION 2 EMBRYOLOGY
    11:00 - 11:25 Human error vs system failure: who is responsible for risk?
    V. Vergara (Spain) 
    11:25 - 11:50 Every step matter building thrust traceablity
    M. Nohales (Spain)     
    11:50 - 12:15 Burnout: A hidden risk to performance in In Vitro Fertilization Laboratories
    M. Basar (USA) 
     12:15 - 12:35 Managing and reporting severe adverse events
    M. G. Almendola (Italy)
    12:35 - 13:00 How safe is embryo culture?
    A. Pinborg (Denmark)
    13:00 - 14:00 LUNCH
SATURDAY 24TH APRIL
09:00 - 10:20
AUDITORIUM ILLES BALEARS 
 CUTTING EDGE CONCEPTS IN GENETICS
09:00 - 09:20 NI embryo assessment: state of the art
D. Sakkas (USA)
09:20 - 09:40 New insights into the clinical predictive value of the vaginal microbiome in IVF cycle
C. Povey (USA)
09:40 - 10:00 Evidence based expanded Carrier screening
D. Babariya (UK)
10:00 - 10:20 Clinical impact of secondary findings following PGT-A
D. Wells (UK)
10:20 - 11:00 COFFEE BREAK
11:00 - 12:00
AUDITORIUM ILLES BALEARS 
 STATE OF THE ART – MALE FACTOR CHALLENGES 
11:00 - 11:20 From stem cells to mature sperm in humans
TBC
11:20 - 11:40 Transplant of human immature testicular tissue
E. Goosens (Belgium)
11:40 - 12:00 Deriving oocytes from pluripotent stem cells
M. Krisiloff (USA)
12:00 - 13:30
AUDITORIUM ILLES BALEARS 
 THE FUTURE IS CLOSER THAN WE THINK
12:00 - 12:20 In vitro gametogenesis from somatic stem cells
K. Hayashi (Japan)
12:20 - 12:40 Reproductive genetics: where we are and where we are going
M. Popovic (Spain)
12:40 - 13:00 Metabolic evaluation and hyperespectral imaging of oocytes and embryos
S. Ojosnegros (Spain)
13:00 - 13:30

Debate 6: Is it the stroma or is it the oocyte?
STROMA: E. Babayev (USA)
OOCYTE: E. Seli (USA)

Important Dates

  • Online Registration
    Early Bird Registration until February 18th, 2027
  • Abstracts
    Abstract Submission form will end on March 10th, 2027